Frontiers in Oncology | Molecular and Cellular Oncology

Review

Published on 25 Aug 2025

High risk factors, molecular features and clinical management for radioactive iodine-refractory differentiated thyroid carcinoma

in Molecular and Cellular Oncology

Tengyun Ma
Yiting Xie
Xinyi Long
Feng Ye

Frontiers in Oncology

doi 10.3389/fonc.2025.1644562

2,654 views
1 citation

Original Research

Published on 22 Aug 2025

EPHA2 promotes triple-negative breast cancer progression by suppressing pyroptosis via the AKT/PI3K/mTOR pathway

in Molecular and Cellular Oncology

Xiaoying Huang
Li Na
Qingkai Han
Qilun Liu
Ligang Wu

Frontiers in Oncology

doi 10.3389/fonc.2025.1620122

2,695 views
1 citation

Brief Research Report

Published on 22 Aug 2025

Raw lacquer-associated familial chronic myelomonocytic leukemia with multi-hit TET2 mutations

in Molecular and Cellular Oncology

Yang Zhang
Yujiao Luo
Hongling Peng
Yafei Yin
Guangsen Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1605369

1,346 views

Mini Review

Published on 22 Aug 2025

Ferroptosis in the tumor microenvironment: mechanisms, advances, and therapeutic perspectives

in Molecular and Cellular Oncology

Weijuan Gao
Jiani Tan
Chengtao Yu

Frontiers in Oncology

doi 10.3389/fonc.2025.1650219

3,765 views
8 citations

Review

Published on 20 Aug 2025

Roles of long non-coding RNA HULC in human digestive system cancers

in Molecular and Cellular Oncology

Liqing Huang

Frontiers in Oncology

doi 10.3389/fonc.2025.1642425

2,853 views
1 citation

Correction

Published on 19 Aug 2025

Correction: Neutrophil extracellular traps and cannabinoids: potential in cancer metastasis

in Molecular and Cellular Oncology

Izabela Krauze
Beata Greb-Markiewicz
Anna Kłopot
Kamila Maciejewska
Michał Bryk
Małgorzata Krzystek-Korpacka

Frontiers in Oncology

doi 10.3389/fonc.2025.1663602

1,139 views

Review

Published on 15 Aug 2025

Cellular senescence in colorectal cancer: its occurrence, effect and therapy

in Molecular and Cellular Oncology

Yabing Liang
Miao Wang
Xianjue Wang
Zhiqing Yang
Shucheng Wang
Fengyi Li
Liya Su
Ling Yang

Frontiers in Oncology

doi 10.3389/fonc.2025.1580951

4,222 views

Case Report

Published on 14 Aug 2025

Mucinous adenocarcinoma of the prostate with extremely low prostate-specific antigen levels, recurrent disease: a case report

in Molecular and Cellular Oncology

Xu Yu
Jie Yuan
Zhiming Wang
Niannian Wang
Xiangfei He
Jie Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1645306

1,284 views

Mini Review

Published on 13 Aug 2025

Molecular mechanism of aerobic exercise in miRNAs and the anti-tumoral effects

in Molecular and Cellular Oncology

Merve Çulha
Fabio S. Lira
Jose C. Rosa-Neto

Frontiers in Oncology

doi 10.3389/fonc.2025.1595982

1,651 views

Review

Published on 13 Aug 2025

Application of artificial intelligence-based stemness index in cancer

in Molecular and Cellular Oncology

Liyuan Liu
Qin Pei
Javeria Qadir
Yiyu Chen
Jingyuan Li
Yanan Luo
Jiawen Xian
Rongrong Du
Ting Ye

Frontiers in Oncology

doi 10.3389/fonc.2025.1608712

1,922 views
1 citation

Original Research

Published on 11 Aug 2025

Cucurbitacin B inhibits HIF-1α and attenuates non-small cell lung cancer via ZFP91

in Molecular and Cellular Oncology

Lei Song
Jing Han
Run Wang
Shen Cao
Yi Tai
Xinyu Wang
Yanjin Zheng
Shufeng Jin
Yue Xing
Hong Xiang Zuo

Frontiers in Oncology

doi 10.3389/fonc.2025.1607264

2,467 views

Systematic Review

Published on 11 Aug 2025

A systematic review and exploration of clinical application of liver depression syndrome in breast cancer

in Molecular and Cellular Oncology

Peng Wu
Siying Mao
Qian Zuo
Qianqian Guo
Qianjun Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1614903

2,819 views

Original Research

Published on 05 Aug 2025

Chorordin-like 1 inhibits pancreatic cancer cell migration and invasion: involvement of the BMP4/SMAD pathway

in Molecular and Cellular Oncology

Wei Li
Yalan Zhong
Yuqiao Song
Hongmei Wang
Zheng Jiang

Frontiers in Oncology

doi 10.3389/fonc.2025.1633464

2,160 views
1 citation

Review

Published on 31 Jul 2025

Advances in research on RNA methylation and cancer radiotherapy resistance

in Molecular and Cellular Oncology

Hui Liu
Hui Luo
Ming Jin
Zhen Zheng
Yang Xi
Kaitai Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1596541

3,018 views
1 citation

Review

Published on 29 Jul 2025

YBX1: an RNA/DNA-binding protein that affects disease progression

in Molecular and Cellular Oncology

Xifeng Zheng
Feng Zeng
Yan Lei
Yanling Li
Jun Deng
Gengqiu Luo
Qian He
Yanhong Zhou

Frontiers in Oncology

doi 10.3389/fonc.2025.1635209

4,521 views
7 citations

Original Research

Published on 28 Jul 2025

The construction and evaluation of a prognostic risk score model for HCC based on MPT-related lncRNAs

in Molecular and Cellular Oncology

Zerun Lin
Jianda Yu
Zhijian Chen
Jingyi Chen
Xiaobin Chi
Honghuan Lin
Yongbiao Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1590094

2,028 views

Review

Published on 25 Jul 2025

The effect of ubiquitination and deubiquitination to imatinib resistance in gastrointestinal stromal tumors

in Molecular and Cellular Oncology

Huade Huo
Haolin Li
Xinlin Yang
Shu Wang
Yan Zhao
Jianjun Yang

Frontiers in Oncology

doi 10.3389/fonc.2025.1581920

2,523 views

Review

Published on 25 Jul 2025

NF-κB signaling pathway in osteosarcoma: from signaling networks to targeted therapy

in Molecular and Cellular Oncology

Juandi Xue
Xiao-ran Yang
Li Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1565760

2,714 views
2 citations

Original Research

Published on 24 Jul 2025

Comparison of [18F]AlF-NOTA-FAPI-04 PET/CT and [18F]FDG PET/CT for diagnosing lymph node metastasis in malignant tumors

in Molecular and Cellular Oncology

Wanjing Zhou
Jiashun Dai
Kai Zheng
Xiang Peng
Yanyin Zhang
Chengzhi Jiang
Jian Yang
Hui Ye

Frontiers in Oncology

doi 10.3389/fonc.2025.1605568

1,625 views

Review

Published on 24 Jul 2025

The bidirectional regulatory network between ATF4 and lncRNAs in systemic diseases

in Molecular and Cellular Oncology

Dongdong Wu
Mei Huang
Changning Ma
Xuetong Xu
Tianhui Wu
Miao Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1562861

1,644 views

Original Research

Published on 23 Jul 2025

Identification of key molecular targets for stachyose in hepatocellular carcinoma: focus on STAT3 and FN1

in Molecular and Cellular Oncology

Haihua Chen
Xianyou Wang
Jiongcheng Ying
YuQin Huang
Yuxi Liu
Yifu Feng
Binbo Fang

Frontiers in Oncology

doi 10.3389/fonc.2025.1576449

1,786 views
1 citation

Original Research

Published on 23 Jul 2025

Complementary detection strategies for circulating tumor cells in breast cancer: clinical implications of combining immunofluorescence and cytopathological staining

in Molecular and Cellular Oncology

Tanja Jesenko
Cvetka Grasic Kuhar
Ziva Pisljar
Simona Miceska
Veronika Kloboves-Prevodnik
Maja Cemazar

Frontiers in Oncology

doi 10.3389/fonc.2025.1632245

2,134 views

Original Research

Published on 21 Jul 2025

Significance of FXa and its receptor PAR2 for the growth of colon cancer cells in vitro and in vivo

in Molecular and Cellular Oncology

Ulrike Meyer
Vincent Rönnpagel
Sophie Grammbauer
Mirjam von Lucadou
Ursula Rauch-Kröhnert
Edzard Schwedhelm
Frank Dombrowski
Christoph Ritter
Bernhard H. Rauch

Frontiers in Oncology

doi 10.3389/fonc.2025.1631350

2,032 views
2 citations

Correction

Published on 21 Jul 2025

Correction: Over-expression of long non-coding RNA-AC099850.3 correlates with tumor progression and poor prognosis in lung adenocarcinoma

in Molecular and Cellular Oncology

Xi Chen
Jishu Guo
Fan Zhou
Wenjun Ren
Jun Pu
Luciano Mutti
Xiaoqun Niu
Xiulin Jiang

Frontiers in Oncology

doi 10.3389/fonc.2025.1641207

971 views

3,144 articles

articles

High risk factors, molecular features and clinical management for radioactive iodine-refractory differentiated thyroid carcinoma

EPHA2 promotes triple-negative breast cancer progression by suppressing pyroptosis via the AKT/PI3K/mTOR pathway

Raw lacquer-associated familial chronic myelomonocytic leukemia with multi-hit TET2 mutations

Ferroptosis in the tumor microenvironment: mechanisms, advances, and therapeutic perspectives

Roles of long non-coding RNA HULC in human digestive system cancers

Correction: Neutrophil extracellular traps and cannabinoids: potential in cancer metastasis

Cellular senescence in colorectal cancer: its occurrence, effect and therapy

Mucinous adenocarcinoma of the prostate with extremely low prostate-specific antigen levels, recurrent disease: a case report

Molecular mechanism of aerobic exercise in miRNAs and the anti-tumoral effects

Application of artificial intelligence-based stemness index in cancer

Cucurbitacin B inhibits HIF-1α and attenuates non-small cell lung cancer via ZFP91

A systematic review and exploration of clinical application of liver depression syndrome in breast cancer

Chorordin-like 1 inhibits pancreatic cancer cell migration and invasion: involvement of the BMP4/SMAD pathway

Advances in research on RNA methylation and cancer radiotherapy resistance

YBX1: an RNA/DNA-binding protein that affects disease progression

The construction and evaluation of a prognostic risk score model for HCC based on MPT-related lncRNAs

The effect of ubiquitination and deubiquitination to imatinib resistance in gastrointestinal stromal tumors

NF-κB signaling pathway in osteosarcoma: from signaling networks to targeted therapy

Comparison of [18F]AlF-NOTA-FAPI-04 PET/CT and [18F]FDG PET/CT for diagnosing lymph node metastasis in malignant tumors

The bidirectional regulatory network between ATF4 and lncRNAs in systemic diseases

Identification of key molecular targets for stachyose in hepatocellular carcinoma: focus on STAT3 and FN1

Complementary detection strategies for circulating tumor cells in breast cancer: clinical implications of combining immunofluorescence and cytopathological staining

Significance of FXa and its receptor PAR2 for the growth of colon cancer cells in vitro and in vivo

Correction: Over-expression of long non-coding RNA-AC099850.3 correlates with tumor progression and poor prognosis in lung adenocarcinoma